You are here

Press Releases

August 8, 2018
Washington, D.C. – AdvaMedDx applauds Capitol Hill's release of technical assistance (TA) developed by the Food and Drug Administration (FDA) to draft legislation authored by Representatives Larry Bucshon (R-IN) and Diana DeGette (D-CO) as a... Read More
May 10, 2018
More than 80 Groups Unite for the First Time to Call for Legislative Reform Washington, D.C. – Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House... Read More
March 21, 2018
WASHINGTON, D.C. - AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that focuses on the value diagnostics bring to patients' health and health care, while addressing the need for regulatory modernization of the... Read More
January 18, 2018
GENEVA, SWITZERLAND – On January 18, the AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR). The Alliance brings together over... Read More
December 7, 2017
Diagnostics Industry Welcomes New Leader WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) which promotes innovation in diagnostic test technology, today announced the appointment of Susan Van Meter,... Read More
September 25, 2017
WASHINGTON, D.C. – AdvaMedDx released the following statement from Executive Director Andy Fish on CMS's recently issued preliminary lab payment amounts for 2018: "Diagnostic tests provide incredible value to the U.S health care system. These tests... Read More
April 6, 2017
Outgoing Chair John Bishop praised for work on passage of Protecting Access to Medicare Act and ongoing work on diagnostic regulatory reform Washington, D.C. – AdvaMedDx today announced that Hologic Chief Operating Officer Eric Compton has been... Read More
March 28, 2017
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, and chief strategy officer of AdvaMed, today issued the following statement regarding release of a discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA) in the U.S.... Read More
January 20, 2017
New Framework Provides Recommendations for Optimizing Diagnostic Solutions to Combat AMR Davos-Klosters, Switzerland – AdvaMedDx, the association representing manufacturers of diagnostic tests to promote wellness, improve patient outcomes, and... Read More
November 21, 2016
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, today issued the following statement regarding FDA’s decision not to release at this time a final guidance on oversight of laboratory developed tests: “AdvaMedDx is disappointed that... Read More